Search research articles
Contact Us
Filters
Showing results (141-150 of 158) with videos related to
Page
of 16
Sort By:
Sleep & Breathing = Schlaf & Atmung
|
October 15, 2015
Comparison of effects of OSA treatment by MAD and by CPAP on cardiac autonomic function during daytime
Martin Glos, Thomas Penzel, Christoph Schoebel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 6, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Raymond L Benza, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 20, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension
Marc Humbert, Gérald Simonneau, David Pittrow, et al.
The Lancet. Respiratory Medicine
|
April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial
Gérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
International Journal of Cancer
|
August 1, 2022
Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)
Ruedi Jung, Simeon J Zürcher, Christina Schindera, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 5, 2022
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Raymond L Benza, David Langleben, Anna R Hemnes, et al.
International Journal of Cardiology
|
May 29, 2020
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE
Raymond L Benza, Paul A Corris, James R Klinger, et al.
Diabetes Care
|
February 3, 2025
Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial
Susanne Thierry, Caspar Joyce Peterson, Stéphanie Pfammatter, et al.
European Journal of Endocrinology
|
January 20, 2017
External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients
Tristan Struja, Marina Kaeslin, Fabienne Boesiger, et al.
Pulmonary Circulation
|
August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies
James R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 158) with videos related to
Sort By:
Page
of 16
Sleep & Breathing = Schlaf & Atmung
|
October 15, 2015
Comparison of effects of OSA treatment by MAD and by CPAP on cardiac autonomic function during daytime
Martin Glos, Thomas Penzel, Christoph Schoebel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 6, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Raymond L Benza, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 20, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension
Marc Humbert, Gérald Simonneau, David Pittrow, et al.
The Lancet. Respiratory Medicine
|
April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial
Gérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
International Journal of Cancer
|
August 1, 2022
Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)
Ruedi Jung, Simeon J Zürcher, Christina Schindera, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 5, 2022
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Raymond L Benza, David Langleben, Anna R Hemnes, et al.
International Journal of Cardiology
|
May 29, 2020
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE
Raymond L Benza, Paul A Corris, James R Klinger, et al.
Diabetes Care
|
February 3, 2025
Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial
Susanne Thierry, Caspar Joyce Peterson, Stéphanie Pfammatter, et al.
European Journal of Endocrinology
|
January 20, 2017
External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients
Tristan Struja, Marina Kaeslin, Fabienne Boesiger, et al.
Pulmonary Circulation
|
August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies
James R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Page
of 16